Interestingly, loss of membranous E-cadherin/β-catenin and increased cytoplasmic ALCAM expression was significantly associated in OSCCs and correlated with aggressive tumor behavior (enhanced tumor invasiveness, late clinical stage, and nodal metastasis). This evidence concerns the gene ALCAM and neoplasm.